The Black Box Warning added to antidepressant labeling in 2004 by the FDA created something of a cottage industry attempting to either discredit it or reverse it. Those efforts are well documented throughout this and many other blogs. And there have been multiple attempts to say that the net effect has been an increase in […]
Investigators Face Trial Amid GSK Sex Tape Revelations Pharmagossip by Jack Friday July 2, 2014 South China Morning Post’s Toh Han Shih reports that British/Chinese-American corporate investigator couple Peter Humphrey and Yu Yingzheng, who were arrested last summer during a bribery investigation into their clients GlaxoSmithKline, will stand trial in Shanghai on July 29th. Chinese prosecutors […]
Before now, J&J et al’s TMAP scheme to sell Atypical Antipsychotics to our government programs held the lead in pharmaceutical greed. But they only replaced a "just as good" generic with expensive in patent drugs. Roche jumped way out front with Tamiflu®, a drug essentially inert as a life-saver sold to governments by the barge […]
I thought we might be getting beyond these industry funded Clinical Trials of psychiatric medications being published in our peer reviewed journals, but they’re still there [though much less frequently]. This one is in the AJP published online last week ahead of print. It tests the effects of Seroquel XR® on patients with Borderline Personality […]